Those are all projects, opportunities and applications that we are working on and will hopefully be in a position to update the market and investors in due course.
Regards,
LF
********************************** Dear Laurent,
I am a current shareholder interested in how everything is progressing in the absence of quarterly reports. Are you able to comment on any of the following:
US BARDA application - BTM/CCS FDA application for Novosorb BTM - surgical wounds Progress of Novosorb TNP post FDA approval. CE Mark application for Novosorb TNP AOD9604 - Full GRAS approval in USA.
I appreciate confidentiality is imperative as a company. Any generic feedback regarding 2014/15 expectations is appreciated.
CZD Price at posting:
10.0¢ Sentiment: LT Buy Disclosure: Held